Index of medicine substances

Niraparib  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Poly (ADP-ribose) polymerase (PARP) inhibitors (L01XK02)

Niraparib + abiraterone  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Poly (ADP-ribose) polymerase (PARP) inhibitors (L01XK52)

Nirmatrelvir + ritonavir  •  Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors (J05AE30)

Nirogacestat  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX81)

Nirsevimab  •  Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies (J06BD08)

Nisoldipine  •  Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives (C08CA07)

Nitisinone  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products (A16AX04)

Nitrazepam  •  Nervous system | Hypnotics and sedatives | Benzodiazepine derivatives (N05CD02)

Nitrendipine  •  Cardiovascular system | Selective calcium channel blockers with mainly vascular effects | Dihydropyridine derivatives (C08CA08)

Nitrendipine + enalapril  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers (C09BB02)

Nitric oxide  •  Respiratory system | Other respiratory system products | Other respiratory system products (R07AX01)

Nitrofurantoin  •  Antiinfectives for systemic use | Other antibacterials | Nitrofuran derivatives (J01XE01)

Nitroglycerine  •  Cardiovascular system | Vasodilators used in cardiac diseases | Organic nitrates (C01DA02)

Nitrous oxide  •  Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics (N01AX13)

Nitrous oxide + oxygen  •  Nervous system | Anesthetics | Anesthetics, general | Other general anesthetics (N01AX63)

Nitroxoline  •  Antiinfectives for systemic use | Other antibacterials (J01XX07)

Nivolumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Pd-1/pdl-1 (programmed cell death protein 1/death ligand 1) inhibitors (L01FF01)

Nivolumab + relatlimab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Combinations of monoclonal antibodies and antibody drug conjugates (L01FY02)

Nizatidine  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists (A02BA04)

Nomegestrol  •  Genito urinary system and sex hormones | Progestogens | Pregnadien derivatives (G03DB04)

Nomegestrol + estradiol  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations (G03AA14)

Nonacog alfa  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD04)

Nonacog beta pegol  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD04)

Nonivamide + nicoboxil  •  Musculo-skeletal system | Topical products for joint and muscular pain | Topical products for joint and muscular pain | Capsaicin and similar agents (M02ABN1)

Noradrenaline  •  Cardiovascular system | Cardiac stimulants excluding cardiac glycosides | Adrenergic and dopaminergic agents (C01CA03)

Norelgestromine + ethinylestradiol  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations (G03AA13)

Norfloxacin  •  Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones (J01MA06)

Norgestimate + ethinylestradiol  •  Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations (G03AA11)

Normal human immunoglobulin  •  Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human (J06BA01)

Normal human immunoglobulin for extravascular administration  •  Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human (J06BA01)